Our recognition
Latest stories
Featured
Hikma delivers strong 2023 performance and a positive outlook for 2024
Press Release, Financial Results
- Hikma appoints Rebecca Hall as Chief Financial Officer Press Release, Corporate 24 September 2026 Hikma appoints Rebecca Hall as Chief Financial Officer
- Hikma R&D Investor Spotlight Series Press Release, Corporate 22 September 2026 Hikma R&D Investor Spotlight Series
- Hikma launches Glucentra® as the first generic semaglutide available to patients in Saudi Arabia Press Release, Product 16 September 2026 Hikma launches Glucentra® as the first generic semaglutide available to patients in Saudi Arabia
- R&D at Hikma | Meet Dima Freihat, helping bring medicines from development to manufacturing Story, Life at Hikma 16 September 2026 R&D at Hikma | Meet Dima Freihat, helping bring medicines from development to manufacturing
Related content